US Patent 7282500 Imidazole-2-carboxamide derivatives as Raf kinase inhibitors

Patent 7282500 was granted and assigned to Smithkline Beecham Limited on October, 2007 by the United States Patent and Trademark Office.

Is a

Current Assignee

Patent Jurisdiction

Patent Number

Patent Inventor Names

Andrew Kenneth Takle0

David Kenneth Dean0

David Matthew Wilson0

Date of Patent

October 16, 2007

Patent Application Number

104781530

Date Filed

May 20, 2002

Patent Primary Examiner

Patent abstract

The present invention relates to compounds of formula (I):

No Timeline data yet.

Title

Author

Link

Type

Date

No Further Resources data yet.

Find more entities like US Patent 7282500 Imidazole-2-carboxamide derivatives as Raf kinase inhibitors

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.